发明名称 CANINE AMNIOTIC MEMBRANE-DERIVED MULTIPOTENT STEM CELLS
摘要 <p>PURPOSE: A canine amniotic membrane-derived multipotent stem cell(cAM-MSC) is provided to ensure excellent proliferation and differentiation ability, and to be used as a cell therapeutic agent. CONSTITUTION: A method for preparing cAM-MSCs comprises: a step of isolating cells from canine amniotic membrane; a step of culturing the cells in a low glucose DMEM; and a step of collecting the cultured cells. The cAM-MSCs has negative immunological property with respect to human markers, CD3, CD11c, CD28, CD34, CD38, CD41a, CD45, and CD62L and has positive immunological property with respect to human markers, CD90 and CD105. The cAM-MSCs are differentiated into ectoderm, mesoderm, or endoderm-derived cells.</p>
申请公布号 KR20130063483(A) 申请公布日期 2013.06.14
申请号 KR20120141334 申请日期 2012.12.06
申请人 KANG STEM HOLDINGS CO., LTD. 发明人 KANG, KYUNG SUN;SEO, MIN SOO;PARK, SANG BUM
分类号 C12N5/074;C12N5/02;C12N5/077;C12Q1/25 主分类号 C12N5/074
代理机构 代理人
主权项
地址